Navigation Links
Tongjitang Chinese Medicines Company Reports Second Quarter 2010 Financial Results
Date:8/18/2010

nal raw materials; uncertainties with respect to the legal system in China, including uncertainty with respect to potential regulatory changes in China's healthcare industry; if disruptions in the financial markets and other macro-economic challenges currently affecting the economy of the United States and other parts of the world continue or even worsen, it may adversely impact the economy and consumer confidence in China; the Company's ability to expand its business through organic growth and strategic acquisitions and investments; and the Company's ability to integrate its acquisitions, including the recently-acquired state-owned distillery business in Guiyang . Further information regarding these and other risks is and will be included in the Company's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F and other filings. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release is as of the date of this press release, and the Company undertakes no duty to update such information, except as required under applicable law.

(1) This announcement contains translations of certain Renminbi amounts into US dollars at specified rates solely for the convenience of readers. Unless otherwise noted, all translations from Renminbi to US dollars as of and for the quarter ended June 30, 2010 were made at the noon buying rate on June 30, 2010 in the City of New York for cable transfers in Renminbi per US dollar as certified for customs purposes by the Federal Reserves Bank of New York, which was RMB6.7815 to USD1.00. Tongjitang makes no representation that the Renminbi or US dollar amounts referred to in this release could have been or could be converted into US dollars or Renminbi, as the case may be, at any particular rate or at all. (2) All references to "shares" are to the Company's ordinary shares. Each
'/>"/>

SOURCE Tongjitang Chinese Medicines Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Tongjitang Files 2009 Annual Report on Form 20-F
2. Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results
3. Tongjitang Chinese Medicines Acquires Guiyang Liquor Factory
4. China Medical Technologies Announces the Use of its HER-2 FISH Probe in a Cancer Targeted Therapy Research Project Sponsored by the Chinese Ministry of Health
5. China BCT Signs Exclusive Distribution Contract With Liujiang County Chinese Medicine Hospital
6. Biosites Triage Products Seized by Beijing Customs; Chinese Market Facing Shortage
7. China Sky One Medical Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology
8. Chinese Distribution Contract Extended for an Additional 4 Years
9. Chinese State Food and Drug Administration Approves Company Facility for Producing Solid Dosage Perindopril
10. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Ofloxacin and Fleroxacin
11. Sinovac Obtains Fifth H1N1 Vaccine Order from Chinese Central Government
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)...  In an effort to raise awareness and the ... DentaQuest established the Health Equity Hero Awards to celebrate ... More than 83 million people in ... care. These barriers are most significant for those who ... language, health literacy or geographic isolation.   "Connecting ...
(Date:5/4/2015)... -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) today announced ... company as Vice President, Medical Affairs. ... Aurora to the Neurocrine team as our Vice ... and Chief Executive Officer of Neurocrine Biosciences. "Bill,s experience ... with his extensive network and influence with psychiatric and ...
(Date:5/4/2015)... 2015 Microbrush International, a leading developer, producer ... restorative procedures, today announced the acquisition of DentiSmart ... sectional matrix system used in dental restorative procedures. ... opportunity to add DentiSmart to our growing portfolio ... VP and General Manager of Microbrush. "DentiSmart,s products ...
Breaking Medicine Technology:DentaQuest Honors Seven Oral Health Leaders As Health Equity Heroes With Inaugural National Award 2DentaQuest Honors Seven Oral Health Leaders As Health Equity Heroes With Inaugural National Award 3DentaQuest Honors Seven Oral Health Leaders As Health Equity Heroes With Inaugural National Award 4Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 2Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 3Microbrush International Announces Acquisition of DentiSmart 2
... NeoStem, Inc. (NYSE Amex: NBS ) ("NeoStem" ... the U.S. and China, commented today on the ruling this ... from funding research involving human embryonic stem cells.  In issuing ... first passed in 1996 prohibiting federal money for research where ...
... KemPharm, Inc. announced today that it has received a ... Trademark Office (USPTO) for its patent application entitled "Non-Standard ... and Using the Same", U.S. Patent No. 7,776,917 B2. ... No. 7,772,222, provides broad protection of the Company,s Ligand ...
Cached Medicine Technology:NeoStem Comments on Recent Court Ruling Blocking the Federal Government's Funding of Embryonic Stem Cell Research 2NeoStem Comments on Recent Court Ruling Blocking the Federal Government's Funding of Embryonic Stem Cell Research 3KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Company's ADHD Prodrug Technology 2KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Company's ADHD Prodrug Technology 3
(Date:5/4/2015)... Jersey (PRWEB) May 04, 2015 Parlin dentist, ... give a chance to more youths to participate and win ... youths in her area to do good deeds and share ... intends to empower their minds and teach them to be ... is accessible to any youth 18 years of age and ...
(Date:5/4/2015)... May 05, 2015 The National ... Hommes as a 2015-2016 inductee into its VIP ... this prestigious distinction for leadership in business. NAPW is ... boasting more than 700,000 members and over 200 operating ... this important honor,” says NAPW President Star Jones. “Her ...
(Date:5/4/2015)... 05, 2015 The National Association ... as a 2015-2016 inductee into its VIP Woman ... prestigious distinction for leadership in healthcare. NAPW is the ... more than 700,000 members and over 200 operating Local ... important honor,” says NAPW President Star Jones. “Her perseverance, ...
(Date:5/4/2015)... 2015 Global Vision, the industry ... today announced that it will showcase Proofware at ... Center, in Nashville Tennessee, May 04 and May ... true all-in-one we-based packaging inspection suite, giving enterprise-wide ... of their brand copy and artwork. Proofware offers ...
(Date:5/4/2015)... Hollywood, California (PRWEB) May 04, 2015 ... of holistic treatment for substance absue, Per Wickstrom, the ... Durkin Entertainment’s EcoLuxe Lounge and the “Salute to the ... the Stardust Penthouse on the top floor of the ... Durkin, Los Angeles’ top producer of sustainable product placement ...
Breaking Medicine News(10 mins):Health News:10 More Days To Enter Good Deed Contest 2Health News:NAPW Inducts Patti Hommes, Director of Advancement Services, Springside Chestnut Hill Academy, a 2015-2016 Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Shirley Weis, President at Weis Associates, LLC, into its 2015-2016 VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Shirley Weis, President at Weis Associates, LLC, into its 2015-2016 VIP Woman of the Year Circle 3Health News:Global Vision to Spotlight Proofware at INFO*FLEX 2015 2Health News:Per Wickstrom Interviews TV and Film Star Carolyn Hennesy About Substance Abuse and Treatment 2
... health benefits of anti-oxidants, more specifically Vitamin E has ... ,Everyday, a number of studies are studies are being ... has warned that under certain circumstances, the even the ... development of cardiovascular disease, cancer and other disorders. ...
... New South Wales have discovered that temporary injury ... fever// could lead to chronic fatigue syndrome (CFS). ... regions of the brain that play a critical role ... glandular fever infection could damage the above-mentioned regions of ...
... regarding an appeal by health officials, requesting the withdrawal of ... Lawyers who are currently handling the case of this severely ... poor and that doctors should be allowed to let him ... treating physicians have not been revealed due to controversies surrounding ...
... Avastin, a cancer drug may cause trigger a rare ... in the New England Journal of Medicine. ... their 50s treated with Avastin developed reversible posterior leukoencephalopathy ... complications. Doctors said that both the patients have recovered. ...
... to the study it was found that GlaxoSmithKline Plc ... against middle-ear infections in infants// said that the vaccine ... maker. ,Roman Prymula, who led the study ... further tests are necessary before the vaccine hits the ...
... comes the news that a stroll followed by a glass of ... individual.// ,This is in the direction of efforts by the ... non-pharmaceutical means to maintain muscle function and quality of life in ... to make athletes out of the elderly, but to increase our ...
Cached Medicine News:Health News:Vitamin E Can Lead To Heart Disease And Cancer 2Health News:Brain Injury, A Consequence Of Glandular Fever Could Trigger Fatigue Syndrome 2Health News:Life Or Death: Parents Await High Court Judgment 2
Solid 14 mm blades. Dull finish....
Angled upward 45 degrees for temporal approach. Open 14 mm blades....
Pediatric model. Blades: 10 mm. Solid blades with locking mechanism. Dull finish....
Speculum with malleable plate to support flap during ablation of thestromal bed....
Medicine Products: